Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Reduced‐Dose Dabrafenib–Trametinib for BRAF V600E–Mutant Lung Adenocarcinoma in a Very Elderly Patient With ECOG PS 2

Saved in:
Bibliographic Details
Published in:Respirology Case Reports
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868552403173769216
collection WordPress RSS
FRELIP Feed Integration
container_title Respirology Case Reports
description
discipline_display Respiratory Diseases
discipline_facet Respiratory Diseases
format Online Article
RSS Article
genre Journal Article
id rss_article:58440
institution FRELIP
journal_source_facet Respirology Case Reports
last_indexed 2026-06-20T21:19:56.163Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Reduced‐Dose Dabrafenib–Trametinib for BRAF V600E–Mutant Lung Adenocarcinoma in a Very Elderly Patient With ECOG PS 2
Respiratory Diseases
General
Respiratory Diseases
sub_discipline_display General
sub_discipline_facet General
subject_display Respiratory Diseases
General
Respiratory Diseases
subject_facet Respiratory Diseases
General
Respiratory Diseases
title Reduced‐Dose Dabrafenib–Trametinib for BRAF V600E–Mutant Lung Adenocarcinoma in a Very Elderly Patient With ECOG PS 2
title_alt Dabrafenib-trametinib a dosis reducida para adenocarcinoma de pulmón con mutación BRAF V600E en un paciente muy anciano con ECOG PS 2
Dabrafénib-tramétinib à dose réduite pour un adénocarcinome pulmonaire mutant BRAF V600E chez un patient très âgé avec ECOG PS 2
Dabrafenibe–Trametinibe em Dose Reduzida para Adenocarcinoma Pulmonar com Mutação BRAF V600E em Paciente Muito Idoso com ECOG PS 2
title_auth Reduced‐Dose Dabrafenib–Trametinib for BRAF V600E–Mutant Lung Adenocarcinoma in a Very Elderly Patient With ECOG PS 2
title_es_txt Dabrafenib-trametinib a dosis reducida para adenocarcinoma de pulmón con mutación BRAF V600E en un paciente muy anciano con ECOG PS 2
title_fr_txt Dabrafénib-tramétinib à dose réduite pour un adénocarcinome pulmonaire mutant BRAF V600E chez un patient très âgé avec ECOG PS 2
title_full Reduced‐Dose Dabrafenib–Trametinib for BRAF V600E–Mutant Lung Adenocarcinoma in a Very Elderly Patient With ECOG PS 2
title_fullStr Reduced‐Dose Dabrafenib–Trametinib for BRAF V600E–Mutant Lung Adenocarcinoma in a Very Elderly Patient With ECOG PS 2
title_full_unstemmed Reduced‐Dose Dabrafenib–Trametinib for BRAF V600E–Mutant Lung Adenocarcinoma in a Very Elderly Patient With ECOG PS 2
title_pt_txt Dabrafenibe–Trametinibe em Dose Reduzida para Adenocarcinoma Pulmonar com Mutação BRAF V600E em Paciente Muito Idoso com ECOG PS 2
title_short Reduced‐Dose Dabrafenib–Trametinib for BRAF V600E–Mutant Lung Adenocarcinoma in a Very Elderly Patient With ECOG PS 2
title_sort reduced‐dose dabrafenib–trametinib for braf v600e–mutant lung adenocarcinoma in a very elderly patient with ecog ps 2
topic Respiratory Diseases
General
Respiratory Diseases
url https://onlinelibrary.wiley.com/doi/10.1002/rcr2.70620?af=R